Kraig Biocraft Laboratories Commissions New Production Rearing Center to Support Accelerating Spider Silk Scale-Up

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a leader in spider silk technology, announced the successful commissioning of a new recombinant spider silk production rearing center in Ann Arbor, Michigan. The facility was operational within 30 days and is already contributing to the company’s April/May 2026 production cycle, which management expects to set new records as part of its commercial-scale expansion. The new center reflects Kraig Labs’ standardized approach to production, allowing rapid duplication of facilities with proven workflows, staffing, and operational systems. CEO Kim Thompson stated the expansion increases both production capacity and efficiency, with each new facility benefiting from lessons learned in prior runs. The multi-facility strategy enhances operational resiliency by distributing production across multiple sites, reducing concentration risk and improving flexibility. The latest facility adheres to the same architecture as previous centers, enabling faster and more efficient scaling. Kraig Labs’ scale-up initiative, launched earlier this year, includes expanded production capacity, new hybrid systems, and increased cocoon processing throughput. The company has achieved consecutive record production runs, positioning the April/May cycle as a major milestone in its commercialization roadmap. Additional production capacity deployments are planned throughout 2026. The company’s leadership in biomaterials was recently highlighted on the cover of the March 2026 issue of *National Geographic*, underscoring the growing significance of its recombinant spider silk efforts.